RNTX
Price
$0.60
Change
+$0.05 (+9.09%)
Updated
Oct 20 closing price
Capitalization
51.34M
17 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$2.19
Change
+$0.14 (+6.83%)
Updated
Oct 20 closing price
Capitalization
134.94M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RNTX vs VYGR

RNTX vs VYGR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
RNTX vs. VYGR commentary
Oct 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNTX is a Buy and VYGR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for RNTX with price predictions
Oct 19, 2026

RNTX's RSI Indicator is remaining in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +7.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where RNTX advanced for three days, in 171 of 216 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

RNTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RNTX as a result. In 84 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for RNTX turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 35 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

RNTX moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RNTX crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. RNTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.034) is normal, around the industry mean (2.978). P/E Ratio (-0.354) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for VYGR with price predictions
Oct 19, 2026

VYGR in downward trend: 10-day moving average moved below 50-day moving average on September 17, 2026

The 10-day moving average for VYGR crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VYGR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for VYGR entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

VYGR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.874) is normal, around the industry mean (2.978). P/E Ratio (-1.210) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (5.263) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. VYGR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VYGR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
RNTX vs VYGR: Fundamental Ratings
RNTX
VYGR
OUTLOOK RATING
1..100
8066
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
1516
SEASONALITY SCORE
1..100
8549

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (47) in the Biotechnology industry is in the same range as RNTX (74) in the null industry. This means that VYGR’s stock grew similarly to RNTX’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RNTX (100) in the null industry. This means that VYGR’s stock grew similarly to RNTX’s over the last 12 months.

VYGR's SMR Rating (98) in the Biotechnology industry is in the same range as RNTX (100) in the null industry. This means that VYGR’s stock grew similarly to RNTX’s over the last 12 months.

VYGR's Price Growth Rating (50) in the Biotechnology industry is in the same range as RNTX (50) in the null industry. This means that VYGR’s stock grew similarly to RNTX’s over the last 12 months.

RNTX's P/E Growth Rating (15) in the null industry is in the same range as VYGR (16) in the Biotechnology industry. This means that RNTX’s stock grew similarly to VYGR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RNTXVYGR
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
COMPARISON
Comparison
Oct 21, 2026
Stock price -- (RNTX: $0.60 vs. VYGR: $2.19)
Brand notoriety: RNTX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNTX: 68% vs. VYGR: 164%
Market capitalization -- RNTX: $51.34M vs. VYGR: $134.94M
RNTX [@Biotechnology] is valued at $51.34M. VYGR’s [@Biotechnology] market capitalization is $134.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.44B. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNTX’s FA Score shows that 1 FA rating(s) are green while VYGR’s FA Score has 1 green FA rating(s).

  • RNTX’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than RNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNTX’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 2 bullish TA indicator(s).

  • RNTX’s TA Score: 4 bullish, 5 bearish.
  • VYGR’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, both RNTX and VYGR are a bad buy in the short-term.

Price Growth

RNTX (@Biotechnology) experienced а -21.14% price change this week, while VYGR (@Biotechnology) price change was +1.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.45%. For the same industry, the average monthly price growth was -16.03%, and the average quarterly price growth was -14.84%.

Reported Earning Dates

RNTX is expected to report earnings on Nov 06, 2026.

VYGR is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-0.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
RNTX
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHVN11.810.46
+4.05%
Biohaven Ltd
GBLI23.750.47
+2.02%
Global Indemnity Group LLC
AOD10.200.09
+0.89%
abrdn Total Dynamic Dividend Fund
TUSB50.45-0.01
-0.02%
Thrivent Ultra Short Bond ETF
YSXT1.47-0.01
-0.68%
YSX Tech Co Ltd

RNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNTX has been loosely correlated with PRLD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RNTX jumps, then PRLD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
+7.81%
PRLD - RNTX
35%
Loosely correlated
+4.13%
RXRX - RNTX
33%
Loosely correlated
+1.39%
SMMT - RNTX
31%
Poorly correlated
+3.34%
BMEA - RNTX
31%
Poorly correlated
-11.96%
VYGR - RNTX
30%
Poorly correlated
+6.83%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with EDIT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+6.83%
EDIT - VYGR
60%
Loosely correlated
+6.61%
RCKT - VYGR
56%
Loosely correlated
+4.46%
KYTX - VYGR
50%
Loosely correlated
+3.60%
SLDB - VYGR
50%
Loosely correlated
+8.11%
MGX - VYGR
49%
Loosely correlated
+2.40%
More